KPC Reports Mixed Financials for Mid-2024
Company Announcements

KPC Reports Mixed Financials for Mid-2024

China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.

KPC, partially owned by China Resources Pharmaceutical Group Ltd., released its unaudited financial results for the first half of 2024, showing a total asset increase of 5.15%, a slight net profit rise of 2.74% for shareholders, and a significant improvement in net cash flow from operating activities by 146.75%. However, revenue saw a decline of 5.73% compared to the previous year. Investors are advised to exercise caution and not solely rely on these results when trading in the company’s securities.

For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskChina Resources Pharmaceutical Completes Green Cross HK Acquisition
TipRanks HongKong Auto-Generated NewsdeskChina Resources Subsidiary Reports Revenue Surge Amid Cash Challenges
TipRanks HongKong Auto-Generated NewsdeskChina Resources Sanjiu Reports Rising Profits Despite Cash Decline
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App